NCT07434609 2026-02-25Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid TumorsNanolattix Biotechnology Co., Ltd.Phase 1 Not yet recruiting150 enrolled
NCT07163325 2025-09-09EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid TumorsEpics TherapeuticsPhase 1 Recruiting48 enrolled